MDT

86.08

+0.56%↑

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

Начало・Списък с акции・CareDx Inc

CareDx Inc

Затворен

СекторЗдравеопазване

21.4 -4.51

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

22.02

Ключови измерители
By Trading Economics
Приходи	-5.8M -4.1M
Продажби	8.3M 108M
P/E Средно за сектора	14.645 63.808
EPS	0.12
Марж на печалбата	-3.79
Служители	761
EBITDA	-5.7M 1.5M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+11.51% upside

Дивиденти
By Dow Jones
Следващи печалби	28.04.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-135M 866M
Предишно отваряне	25.91
Предишно затваряне	21.4

Настроения в новините

By Acuity

49%

51%

167 / 348 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Neutral Evidence

14.77 / 18.49 Подкрепа & съпротива

CareDx Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

17.04.2026 г., 20:26 ч. UTC

Придобивния, сливания и поглъщания

UCB to Buy Neurona Therapeutics for Up to $1.15 Billion

17.04.2026 г., 18:15 ч. UTC

Значими събития в новините

Fed's Waller: Prolonged Iran Conflict Could Block Path to Rate Cuts

17.04.2026 г., 16:49 ч. UTC

Значими събития в новините

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

17.04.2026 г., 16:49 ч. UTC

Значими събития в новините

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI Data Due as Focus Remains on Middle East

17.04.2026 г., 22:58 ч. UTC

Печалби

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17.04.2026 г., 21:32 ч. UTC

Пазарно говорене

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17.04.2026 г., 21:22 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

17.04.2026 г., 21:22 ч. UTC

Пазарно говорене

Moody's Downgrades Belgium to A1 -- Market Talk

17.04.2026 г., 20:52 ч. UTC

Печалби

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17.04.2026 г., 20:50 ч. UTC

Пазарно говорене

Печалби

Придобивния, сливания и поглъщания

Tech, Media & Telecom Roundup: Market Talk

17.04.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

17.04.2026 г., 20:29 ч. UTC

Печалби

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

17.04.2026 г., 20:11 ч. UTC

Придобивния, сливания и поглъщания

UCB to Buy Neurona Therapeutics for Up to $1.15B

17.04.2026 г., 19:34 ч. UTC

Пазарно говорене

Печалби

Придобивния, сливания и поглъщания

Global Equities Roundup: Market Talk

17.04.2026 г., 19:34 ч. UTC

Пазарно говорене

Печалби

Придобивния, сливания и поглъщания

Analysts See Netflix's Deal Commentary as Notable -- Market Talk

17.04.2026 г., 19:31 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Futures Fall on Reopening of Strait of Hormuz -- Market Talk

17.04.2026 г., 19:26 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Edge Up -- Market Talk

17.04.2026 г., 19:21 ч. UTC

Пазарно говорене

Albemarle's Outperformance Belies Longer-Term Risks -- Market Talk

17.04.2026 г., 19:15 ч. UTC

Пазарно говорене

Danaher Seen Rebounding in 2H After Tools-Sector Weakness -- Market Talk

17.04.2026 г., 19:07 ч. UTC

Пазарно говорене

Danaher Faces Tough Comparative but Long‑Term Story Intact -- Market Talk

17.04.2026 г., 18:57 ч. UTC

Значими събития в новините

U.S. Stocks Surge on Hope Iran War Nearing End. Foreign Leaders Have a More Sober View. -- Barrons.com

17.04.2026 г., 18:53 ч. UTC

Придобивния, сливания и поглъщания

UCB Expects 2026 Adjusted Ebitda Growth in High Single-Digit to Mid-Teens Percentage Range at Constant Exchange Rates

17.04.2026 г., 18:53 ч. UTC

Придобивния, сливания и поглъщания

UCB 2026 Rev Guidance Unchanged

17.04.2026 г., 18:52 ч. UTC

Придобивния, сливания и поглъщания

UCB: Neurona Deal to Include $650M Upfront and Up to $500M in Potential Future Milestones

17.04.2026 г., 18:52 ч. UTC

Придобивния, сливания и поглъщания

UCB to Acquire Neurona Therapeutics for Up to $1.15B Including Potential Milestones

17.04.2026 г., 18:14 ч. UTC

Пазарно говорене

Значими събития в новините

Precious Metals Close Higher as Stronger Demand Eyed -- Market Talk

17.04.2026 г., 18:00 ч. UTC

Значими събития в новините

Fed's Waller: Quick Resolution in Middle East Could Allow Cuts Later This Year

17.04.2026 г., 18:00 ч. UTC

Значими събития в новините

Fed's Waller: Job Losses May Not Signal Recession Amid Demographic Changes

17.04.2026 г., 17:31 ч. UTC

Пазарно говорене

Значими събития в новините

U.S. Oil Rig Count Down By 1 at 410 -- Market Talk

17.04.2026 г., 17:26 ч. UTC

Пазарно говорене

Печалби

Netflix's Ability to Grow Engagement Seen as Up in the Air -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

CareDx Inc Прогноза

Ценова цел

By TipRanks

11.51% нагоре

12-месечна прогноза

Среден 25 USD 11.51%

Висок 28 USD

Нисък 21 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за CareDx Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

6 ratings

Купи

Задържане

Продай

Според 6 анализатори, дали борсови рейтинги на CareDx Inc през последните 3 месеца.

Техническа оценка

By Trading Central

14.77 / 18.49Подкрепа & съпротива

The bullish and bearish events are balanced.

All events are bearish.

Bearish events outweigh bullish events.

Настроение

By Acuity

167 / 348 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.